IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA

Rheumatology

Volumn 47, Issue 10, 2008, Pages 1489-1492

  Engelmann, Robby ^a   Brandt, J ^b,c   Eggert, M ^d   Karberg, K ^b   Krause, A ^e   Neeck, G ^d   Mueller hilke, B ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b Practice for Rheumatology ^*  (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Hospital Bad Doberan   (Germany)

^e Clinic for Rheumatology in Berlin Wannsee   (Germany)

Author keywords

Auto antibodies; Cyclic citrullinated peptides; IgG subclasses; Mutated citrullinated vimentin; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MICROTITER PLATE ASSAY; PLASMA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; TH2 CELL; VARICELLA ZOSTER VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PEPTIDES, CYCLIC; VIMENTIN;

EID: 52949135227     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken336     Document Type: Article

References (16)

1. Knedla A, Neumann E, Muller-Ladner U. Developments in the synovial biology field 2006. Arthritis Res Ther 2007;9:209.
2. Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008;26:651-75.
3. Mathsson L, Mullazehi M, Wick MC et al. Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated-peptides. Arthritis Rheum 2008;58:36-45.
4. Chapuy-Regaud S, Nogueira L, Clavel C et al. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol 2005;139:542-50.
5. Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA et al Isotype distribubon of anti-cylic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 2006;54:3799-808.
6. van der Neut KM, Schuurman J, Losen M et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007;317:1554-7.
7. Bos WH, Bartelds GM, Vis M et al. Preferential decrease of IgG4 anti-citrullinated protein antibodies during treatment with TNF blocking agents in patients with rheumatoid arthritis. Ann Rheum Dis. Advance Access published April 29, 2008, doi: 0: ard.2008.088401v1.
8. Holland M, Hewins P, Goodall M et al. Anti-neutrophil cytoplasm antibody IgG. subclasses in Wegener's granulomatosis: A possible pathogenic role for the IgG4 subclass. Clin Exp Immunal 2004;138:183-92.
9. Blanco F, Kalsi J, Ravirajan CT et al. IgG subdasses in systemic lupus erythematosus and other autoimmune rheumatic diseases. Lupus 1992;1:391-9.
10. Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol 1996;8:199-205.
11. Magalhaes R, Stiehl P, Morawietz L, Berek C, Krenn V. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 2002;441:415-27.
12. Knutsen AP, Spectrum of antibody deficiency disorders with normal or near-normal immunoglobulin levels. Pedatr Asthma Allergy Immunol 2006;19:51-62.
13. Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006;4:23.
14. Mihai S, Chiriac MT, Herrero-Ganzalez JE et al. IgG4 autoantibodies induce dermalepidermal separation. J Cell Mol Med 2007;11:1117-28.
15. Nimmerjahn F, Ravetch JV. Fogamma receptors as regulators of immune responses. Nat Rev Immunol 2008;8:34-47.
16. Radstake TR, Franke B, Wenink MH et al. The functional variant of the inhibitory Fcgamma receptor Ilb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis. Arthritis Rheum 2006;54:3828-37.